IP Library Granted Patent US 12,221,632
Granted Patent B2
US 12,221,632 · App. 17/389,371 · Granted Feb 11, 2025

Virus lysis and nucleic acid preservation solution

Inventors: Yuandong Liu (Guangzhou, CN); Wei Meng (Guangzhou, CN); Meiying Chen (Guangzhou, CN); Qin Huang (Guangzhou, CN); Qingqing Chen (Guangzhou, CN); Ning Zhou (Guangzhou, CN)
Assignee: GUANGZHOU DONGSHENG BIOTECH CO., LTD.
C12N7/00C12N15/1013
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,221,632
App. No.
17/389,371
Granted
Feb 11, 2025
Kind
B2
Abstract

A virus lysis and nucleic acid preservation solution is disclosed, including the following components: isopropanol or ethyl alcohol, guanidinium chloride, tri (hydroxymethyl) aminomethane hydrochloride, and ethylenediaminetetraacetic acid. Furthermore, a kit including the virus lysis and nucleic acid preservation solution, a method for preserving viral nucleic acid, and a method for extracting a viral nucleic acid are also provided. The virus lysis and nucleic acid preservation solution of the present invention has the functions of lysing virus and preserving nucleic acid in the lysed virus samples, and it is compatible with lysis buffers, wash buffers, elution buffers, etc. in all kinds of viral nucleic acid extraction kit commonly available in the market.

Claims (19)

1. A virus lysis and nucleic acid preservation solution, comprising the following components:

isopropanol or ethyl alcohol,

guanidine hydrochloride,

tris (hydroxymethyl) aminomethane hydrochloride,

ethylenediaminetetraacetic acid,

proteinase K and

magnetic beads, wherein a concentration of the guanidine hydrochloride is 5-6 mol/L, a concentration of the tris (hydroxymethyl) aminomethane hydrochloride is 10-100 mmol/L, a concentration of the ethylenediaminetetraacetic acid is 2-5 mmol/L, and a volume percentage of the isopropanol or ethyl alcohol is 5%-40%, wherein the magnetic beads are hydroxyl magnetic beads, and wherein the guanidine hydrochloride in the virus lysis and nucleic acid preservation solution does not cause proteinase K inactivation or aggregation of the magnetic beads.

2. The virus lysis and nucleic acid preservation solution according to claim 1 , wherein in the virus lysis and nucleic acid preservation solution, the concentration of the guanidine hydrochloride is 5 mol/L, the concentration of the tris (hydroxymethyl) aminomethane hydrochloride is 50-80 mmol/L, and the concentration of the ethylenediaminetetraacetic acid is 2.5-4 mmol/L, and the volume percentage of the isopropanol or ethanol is 10%-30%.

3. The virus lysis and nucleic acid preservation solution according to claim 1 , wherein a pH of the virus lysis and nucleic acid preservation solution is 6-9.

4. The virus lysis and nucleic acid preservation solution according to claim 3 , wherein a pH of the virus lysis and nucleic acid preservation solution is 7-8.

5. The virus lysis and nucleic acid preservation solution according to claim 1 , wherein the virus lysis and nucleic acid preservation solution is prepared with sterile water as a solvent.

6. A kit, comprising the virus lysis and nucleic acid preservation solution according to claim 1 , wherein the kit is configured for a virus preservation and/or a nucleic acid extraction.

7. A method for preserving viral nucleic acid comprising a step of adding the solution according to claim 1 to a sample containing a virus.

8. The virus lysis and nucleic acid preservation solution according to claim 2 , wherein a pH of the virus lysis and nucleic acid preservation solution is 6-9.

9. The virus lysis and nucleic acid preservation solution according to claim 2 , wherein the virus lysis and nucleic acid preservation solution is prepared with sterile water as a solvent.

10. The kit according to claim 6 , wherein in the virus lysis and nucleic acid preservation solution, the concentration of the guanidine hydrochloride is 5 mol/L, the concentration of the tris (hydroxymethyl) aminomethane hydrochloride is 50-80 mmol/L, the concentration of the ethylenediaminetetraacetic acid is 2.5-4 mmol/L, and the volume percentage of the isopropanol or ethanol is 10%-30%.

11. The kit according to claim 6 , wherein a pH of the virus lysis and nucleic acid preservation solution is 6-9.

12. The kit according to claim 11 , wherein a pH of the virus lysis and nucleic acid preservation solution is 7-8.

13. The kit according to claim 6 , wherein the virus lysis and nucleic acid preservation solution is prepared with sterile water as a solvent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2021
From: LIU, YUANDONG; MENG, WEI; CHEN, MEIYING; HUANG, QIN; CHEN, QINGQING; ZHOU, NING
To: GUANGZHOU DONGSHENG BIOTECH CO., LTD.
Reel/Frame 057028/0565 →
Priority Claims (1)
CN 202010571607.0 · Jun 22, 2020 · national
Continuity (2)
Continuation PCTCN2021074681 · Feb 1, 2021
Related Publication 20220017874A1 · Jan 20, 2022
References Cited (15)
US 9999217B2 · Whitney · 2018 [cited by examiner]
US 10174362B2 · Gaeta · 2019 [cited by examiner]
US 20140065627A1 · Whitney · 2014 [cited by examiner]
CN 106906207A · 2017 [cited by applicant]
CN 109207476A · 2019 [cited by applicant]
CN 109971749A · 2019 [cited by applicant]
CN 111172239A · 2020 [cited by applicant]
CN 111235145A · 2020 [cited by examiner]
CN 111304175A · 2020 [cited by examiner]
CN 111690640A · 2020 [cited by applicant]
Tris-HCI Buffer Recipe. Cold Spring Harbor Protocol (2006). doi:10.1101/pdb.rec8747 (Year: 2006). [cited by examiner]
Scallan et al (Apr. 13, 2020). Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-COV-2 RNA for COVID-19 . . . Lysis Buffers Containing 4 to 6 M GITC, Roche E… [cited by examiner]
Li et al (2018). Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol. 2018;28:e1963. (Year: 2018). [cited by examiner]
Zhao et al (Feb. 27, 2020). A simple magnetic nanoparticles-based viral RNA extraction method for efficient detection of SARS-CoV-2. bioRxiv (2020) pp. 1-18. (Year: 2020). [cited by examiner]
J. Sambrook, et al., Molecular Cloning: A Laboratory Manual, pp. 936-939, China Science Press Co., Ltd. [cited by applicant]